Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01367184
Other study ID # AVR-IVC-01
Secondary ID
Status Terminated
Phase N/A
First received June 3, 2011
Last updated June 20, 2013
Start date May 2011
Est. completion date May 2014

Study information

Verified date June 2013
Source American Venous Forum
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

Inferior vena cava (IVC) filter is an important therapeutic device used in the management of venous thrombo-embolism (VTE) in patients that are contra-indicated for anti-coagulation therapy. While there has been significant increase in the use of filters , unfortunately there are no standardized collection of data to track, compare outcomes, report safety and efficacy.


Description:

The registry is a multi-institutional bioinformatics database for the collection of data relevant to Inferior vena cava filters. Participating study centers may enroll patients and enter data in the web-based registry that include demographics, clinical features, management details and follow-up up to 48 months.

The purpose of this study is to improve our understanding of the retrieval rate, long term safety and efficacy on IVC filters placed in North America.


Recruitment information / eligibility

Status Terminated
Enrollment 20000
Est. completion date May 2014
Est. primary completion date April 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Data obtained in line with good clinical practice,applicable laws and regulation

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Locations

Country Name City State
United States Northwest Texas Hospital Amarillo Texas
United States University Of Michigan Health System Ann Arbor Michigan
United States St. Luke's Medical Center Chesterfield Missouri
United States University of Chicago Hospitals Chicago Illinois
United States Good Samaritan Hospital Cincinnati Ohio
United States Palmetto Health and Providence Hospital Columbia South Carolina
United States Exempla Lutheran Medical Center Denver Colorado
United States Doylestown Hospital Doylestown Pennsylvania
United States University of Florida , Division of Vascular Surgery & Endovascular Therapy Gainesville Florida
United States University of Texas Medical Branch Galveston Texas
United States Vascular Health Alliance, Greenville Hospital System Greenville South Carolina
United States St Peters Hospital Helena Montana
United States Eastern Idaho Regional Medical Center Idaho Falls Idaho
United States Lancaster General Hospital Lancaster Pennsylvania
United States University Of Kentucky , Vascular and Endovascular Divison Lexington Kentucky
United States Medical Center of Central Georgia Macon Georgia
United States West Virginia University Healthcare Morgantown West Virginia
United States Intermountain Medical Center Murray Utah
United States Tuoro Infirmary New Orleans Louisiana
United States Brooklyn Hospital New York New York
United States University of Pittsburgh School of Medicine Division of Vascular Surgery Pittsburgh Pennsylvania
United States University Of Rochester Medical Center Rochester New York
United States Southern Illinois University School of Medicine Springfield Illinois
United States Bayfront Medical Center St Petersburg Florida
United States Stony Brook University Medical Center, Vein Clinic Stony Brook New York
United States Jobst Vascular Institute Toledo Ohio
United States Avera Sacred Heart Hospital Yankton South Dakota

Sponsors (1)

Lead Sponsor Collaborator
American Venous Forum

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Integrity of IVC Filter 12 months post placement 48 Months Yes

External Links